[Event Report] The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) (January 22, 2020)
date : 2/11/2020
Tags: AMR
![[Event Report] The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) (January 22, 2020)](https://hgpi.org/en/wp-content/uploads/sites/2/AMIC-top.jpg)
Nikkei Inc. and AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) jointly held the First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC).
At this first sub-committee, participants from academia, the Government, industry and civil society discussed potential policy options to ensure sustainable research and development (R&D) for antimicrobials.
Participants agreed to continue to discuss the state of the antimicrobial market in working groups toward the eventual formulation of a concrete proposal on ways to incentivize antimicrobial R&D in the future.
■Overview
Date and time: Wednesday, January 22, 2020
Organizer: AMR Alliance Japan (Secretariat: HGPI)
■Program
The role of the AMR sub-committee
Mitsuru Miyata (Adviser, Medical and Healthcare Division, Nikkei Business Publications, Inc.)
Shigeru Omi (President, Japan Community Health care Organization (JCHO) / Regional Director Emeritus, Regional Office for the Western Pacific (WPRO), World Health Organization (WHO))
AMR Alliance Japan
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute (AMR Alliance Japan Secretariat))
Kazuhiro Tateda (President, The Japanese Association for Infectious Diseases / President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)
Discussion —Policy options to revitalize the antimicrobial industry
From the perspective of the Cabinet Secretariat:
Hiroyuki Noda (Councilor, Coordination Office of Measures on Emerging Infectious Diseases, Office of Pandemic Influenza and New Infectious Diseases Preparedness and Response, Cabinet Secretariat)
From the perspective of the Ministry of Health, Labour and Welfare:
Manami Yanagawa (Chief, Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare (MHLW))
From the perspective of the pharmaceutical industry
Takeo Morooka (Executive Officer, Head of Health Policy and Corporate Support, MSD K.K.) Takuko Sawada (Executive Vice President, Shionogi & Co., Ltd.)
Chairs:
Shigeru Omi (President, Japan Community Health care Organization (JCHO) / Regional Director Emeritus, Regional Office for the Western Pacific (WPRO), World Health Organization (WHO))
Kazuhiro Tateda (President, The Japanese Association for Infectious Diseases / President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)
Facilitator:
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute (AMR Alliance Japan Secretariat))
Top Research & Recommendations Posts
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Cancer Control Project “Policy Recommendations on Addressing Regional Disparities in Breast Cancer Care” (January 31, 2025)
- [Research Report] Comparative Research Group on Local Regulations for Dementia Presents Final Report, “Toward Dementia Regulations for an Inclusive Society” (December 27, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Public Comment Submission] “Plan for Global Warming Countermeasures (Draft)” (January 26, 2025)
- [Research Report] 2019 Survey on Healthcare in Japan
Featured Posts
-
2025-01-22
[Registration Closed] HGPI Salon 2025 “Looking Ahead to the Future of Japan’s Social Security System” Session 1: Improving Productivity through the Streamlining of Healthcare and Long-Term Care Services and the Utilization of ICT (February 14, 2025)
-
2025-01-31
[Research Report] Comparative Research Group on Local Regulations for Dementia Presents Final Report, “Toward Dementia Regulations for an Inclusive Society” (December 27, 2024)
-
2025-02-01
[Announcement] Announcement of the 1st Kiyoshi Kurokawa Award Recipient
-
2025-02-07
[Publication Report] The Child Health Project Publishes Family Mental Health Booklet “Learning and Practicing at Home – Stress Management for Children with Intellectual Disabilities” (February 3, 2025)
-
2025-02-12
[Registration Open] (Webinar) The 131st HGPI Seminar “The Policy Process of the Kyoto City Caregiver Ordinance” (March 19, 2025)